secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001683168-26-003203
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences grants 100,000 restricted shares to Interim CEO James Parslow
--------------------------------------------------------------------------------

- Grant of 100,000 restricted shares to James Parslow, Interim CEO and CFO.
- 7,000 shares vest immediately; 31,000 vest on each of 1st, 2nd, 3rd anniversaries of April 21, 2026.
- All unvested shares accelerate upon a Change in Control.
- Award is under Amended and Restated Equity Incentive Plan; grant agreement filed as Exhibit 10.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316826003203/0001683168-26-003203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316826003203/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-003203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer